Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Filings indexed 992 across all filing types
Latest filing 2021-05-21 Board/Management Inform…
Country FI Finland
Listing HE BIOBV

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
Changes to Biohit Oyj’s management
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the departure of the company's CFO and the initiation of a search for a replacement. This falls directly under the definition of an announcement of changes in senior management.
2021-05-21 English
Biohit Oyj’s President and CEO Semi Korpela to leave the company
Board/Management Information Classification · 100% confidence The document is a stock exchange release announcing the immediate departure of the company's President and CEO, Semi Korpela, and the appointment of an interim deputy CEO. This falls directly under the category of management changes within the company's leadership structure.
2021-05-17 English
Biohit corporation initiates arbitration proceedings concerning a breach of the license agreement
Legal Proceedings Report Classification · 95% confidence The document is a stock exchange release announcing that Biohit Oyj has initiated arbitration proceedings against a distributor due to a breach of a license agreement and unpaid royalties. This constitutes a legal dispute and regulatory disclosure regarding significant corporate litigation. As it details a specific legal action/proceeding, it fits the 'Legal Proceedings Report' category.
2021-05-17 English
Biohit oyj aloittaa lisenssisopimuksen rikkomista koskevan välimiesmenettelyn
Legal Proceedings Report Classification · 95% confidence The document is a stock exchange release (Pörssitiedote) announcing that Biohit Oyj has initiated arbitration proceedings against its distributor, Biohit HealthCare (Hefei) Co. Ltd, due to a breach of a license agreement and unpaid royalties. This document describes a legal dispute and the initiation of formal arbitration, which falls under the category of legal proceedings or regulatory announcements. Since it does not fit into specific categories like M&A or financial reporting, and it is a formal regulatory announcement regarding a legal matter, it is classified as a Legal Proceedings Report (LTR).
2021-05-17 Finnish
Biohit Oyj:n toimitusjohtaja Semi Korpela jättää yhtiön
Board/Management Information Classification · 100% confidence The document is a stock exchange release announcing the immediate departure of the company's CEO, Semi Korpela, and the appointment of an interim replacement. This falls directly under the category of changes in senior management.
2021-05-17 Finnish
Biohit_ Annual report_2020.pdf
Annual Report Classification · 100% confidence The document is explicitly titled '2020 ANNUAL REPORT' and contains comprehensive sections including 'CEO's Review', 'Strategy', 'Corporate Governance', and 'Financial Statements'. It provides a detailed overview of the company's performance, key figures, and business outlook for the fiscal year 2020. It meets all the criteria for an Annual Report (10-K). FY 2020
2021-03-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.